Rheumatoid factors found in patients with rheumatoid arthritis react with human IgG and with IgG from some other species. The levels of rheumatoid factor give some indication of prognosis, albeit a rather poor one in this highly variable disease. The high degree ofvariability may, in part, be due to differences in the fine specificity of the rheumatoid factor in each individual patient, leading to differences in the types ofimmune complex formed. Serum (1 1d) was added to each well with 100 1t 0 05 M TRIS HCI pH 8-0 containing 0 05% Tween 20 (TRIS HCI Tween), and incubated for one hour at 37°C (serum dilution 1:100). The plates were then washed three times with cold TRIS HCI Tween.
Rheumatoid factors bind to normal human IgG and IgG from many different species.' It is long established that raised levels of such antiglobulins are associated with rheumatoid arthritis and that this antiglobulin activity is found in IgM, IgA, and IgG classes. 2 The degree of binding of rheumatoid factor to IgG of different species is controversial, as is the clinical significance of the spectrum of such polyspecific rheumatoid factor activity. Some have shown that rheumatoid factors binding with rabbit IgG are more specific for rheumatoid arthritis than are those reactive with human IgG. 3 4 In contrast, others suggest that human rather than rabbit IgG is a better discriminator between patients with rheumatoid arthritis and controls.5 It has been shown that rheumatoid factor binding to human IgG has similar binding activity with the primate rhesus monkey IgG, but lower binding with non-primate rabbit, horse, sheep, and cow. 6 The aim of this study was to examine the fine specificity of rheumatoid factors in each of the three main classes, IgM, IgA, and IgG, and to compare these results with various measures of disease process and outcome (particularly degree of erosiveness and presence of extra-articular manifestations) to see if any can be linked to a particular isotype or specificity of rheumatoid factor. The specificities were measured with a panel of IgGs from a variety of primate and nonprimate species and their relation to disease activity at the time of drawing the blood was established. To discover whether the pattern of reactivity with the panel of IgGs had any predictive value stored sera from patients with rheumatoid arthritis were studied and the results compared with their outcome at long term follow up.
Materials and methods
IgG PREPARATION IgG from various species was purified by passing the serum over a DEAE-cellulose column and eluting with a gradient of increasing molarity of 0-017 M to 0-5 M phosphate buffer pH 8- Proteins at a concentration of27 mg/ml optimally were incubated at 63°C for 30 minutes and then placed on ice. The degree of aggregation was then checked by gel filtration on a Sephacryl S300 column. PATIENT 
SELECTION
The patients were part of a prospective study established at the Middlesex Hospital in 1966.7 Each patient entered the study within one year of onset of polyarthritis satisfying the criteria for at least possible rheumatoid arthritis (American Rheumatism Association criteria), other causes of inflammatory polyarthritis having been excluded. The patients attend a special research clinic about three times a year for clinical, radiological, and serological examination. The serum samples under test were taken within a year of the patient entering the study and have been stored deep frozen at -20°C since then. The degree of erosion in hand and feet radiographs was assessed by a modification of the method of Lawrence8 at a minimum of 10 years' follow up.
STATISTICAL METHODS
Friedman's test was used to test for significant patterns in the antiglobulin results.9 10 The significance of differences in a solid phase by at least one of its combining sites was then allowed to bind soluble phase labelled IgG of various species by its remaining antigen combining sites. The affinity of the rheumatoid factor was found to be too low to bind monomeric IgG in the soluble phase, but mildly heat aggregated human IgG was bound well by the rheumatoid factors. The assay was found to depend largely on IgM rheumatoid factor as reduction with dithiothreitol abolished the binding. All preparations of species of IgG were found to be similarly aggregated by heat as identical profiles were obtained when the aggregates were run through a Sephacryl S300 gel filtration column.
Using this assay with human IgG on the solid phase, we found that the rheumatoid factors could only bind human and baboon IgG from the soluble phase, with no binding of IgG prepared from rabbit, horse, marmoset, bovine, macaque, chimpanzee, gorilla, owl monkey, or orang-utan (fig 4) . Using a discriminant analysis of the results obtained from the earliest available serum sample from these patients, all seen within one year of onset of a polyarthritis which satisfied, as a minimum, the criteria for 'possible' rheumatoid arthritis, we were able to discriminate completely between the patients who went on to develop mild erosive changes or none at all and those who developed moderate or severe erosions.
To achieve this 100% discrimination a combination of antiglobulin tests was used. The panel was selected by the discriminant analysis programme and ranked in importance. When the discrimination obtained with different isotypes was compared IgM gave the greatest discrimination followed by IgA and IgG. The most discriminating individual factors are IgM antiglobulins with specificities for IgG from species closely related to man but not to human IgG itself. This may suggest that the antiglobulins bind to an altered human IgG, possibly one which has undergone mutation or has altered glycosylation,12 and that the altered form is more like, say, gorilla IgG than unaltered human IgG. It may also be argued, however, that the specificities detected in the serum are those which are non-complexed, and that the specifically antihuman IgG has been complexed by the large pool of human IgG in the serum and is thus not available for test in the serum samples. There is evidence to suggest that rheumatoid factors released from cells have higher affinities than those found in the serum, implying local complexing of the rheumatoid factor."3 The finding that rheumatoid factors freshly released from synovial cells are able to bind IgG3, in contrast with serum rheumatoid factor, indicates that serum may contain a more limited range of specificities than those in synovial cells.14 When the solid phase capture assay was used, however, only mildly aggregated human and baboon IgG were bound by the IgM rheumatoid factor, which suggests that the IgM rheumatoid factor has a higher affinity for human and baboon IgG; on an evolutionary basis gorilla and chimpanzee are closer to human as they are in the same superfamily, 16 One of the aims of a long term study such as the Middlesex prospective study is to set up hypotheses for the earlier patients and then to test them on a later group of patients. The ability to predict in the second group of 40 patients using the discriminant function derived from the first 48 is disappointing, being only 65% accurate; the discrimination on the first group from which the panel was derived being 100%. This may reflect either the fact that a larger initial group is required for the development of satisfactory predictive data, or perhaps, more probably, that the patients enrolled had several different and as yet unrecognised subtypes ofdisease which are differently represented in the two groups. Possibly, fitting the data to be 100% perfect makes the equation too restrictive to one set of patients. Setting the limits at, say, 95% may result in a more representative function, which could be more satisfactorily applied to another group of patients.
It was striking that using Friedman's analysis highly significant trends were obtained, indicating that those patients ranking highest for one species of IgG would also be the same patients with the highest activity for the whole panel. This rules out the hypothesis that certain patients might bind strongly to some species of IgG while binding weakly to others. Thus it seems that the different courses of disease are not related to the pattern of antiglobulin reactivity detected in the serum, but that the most significant risk factor for development of erosiveness is the amount of antiglobulin formed.
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